Lumryz
- Product NDC
- 13551-003
- 11-digit product format
- 135510003
- Labeler code
- 13551
- Product ID
- 13551-003_bd9a6c48-be50-44e5-8cbb-87cbaafe936d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- sodium oxybate
- Dosage form
- FOR SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Avadel CNS Pharmaceuticals, LLC
- Application
- NDA214755
- Marketing category
- NDA
- Marketing start
- 2023-05-01
- Substance
- SODIUM OXYBATE
- Active strength
- 7.5 g/1
- Pharmacologic classes
- Central Nervous System Depressant [EPC], Central Nervous System Depression [PE], Decreased Central Nervous System Organized Electrical Activity [PE]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N214755-001 | LUMRYZ | SODIUM OXYBATE | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | |
| N214755-002 | LUMRYZ | SODIUM OXYBATE | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | |
| N214755-003 | LUMRYZ | SODIUM OXYBATE | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | |
| N214755-004 | LUMRYZ | SODIUM OXYBATE | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N214755-001 | 10272062 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-001 | 10736866 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-001 | 10952986 | 2037-07-21 | U-3601 | 2023-05-23 | |
| N214755-001 | 10973795 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-001 | 11000498 | 2037-07-21 | U-3580 | Drug product | 2023-05-23 |
| N214755-001 | 11052061 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-001 | 11065224 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-001 | 11400065 | 2037-07-21 | U-3579 | 2023-05-23 | |
| N214755-001 | 11504347 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-001 | 11602512 | 2037-07-21 | U-3577 | 2023-05-23 | |
| N214755-001 | 11602513 | 2037-07-21 | U-3576 | 2023-05-23 | |
| N214755-001 | 11766418 | 2037-07-21 | Drug product | 2023-09-29 | |
| N214755-001 | 11839597 | 2037-07-21 | Drug product | 2024-01-04 | |
| N214755-001 | 11896572 | 2037-07-21 | Drug product | 2024-02-20 | |
| N214755-001 | 11986451 | 2037-07-21 | U-3934 | 2024-05-29 | |
| N214755-001 | 12097175 | 2037-07-21 | Drug product | 2024-10-15 | |
| N214755-001 | 12097176 | 2037-07-21 | U-4006 | 2024-10-15 | |
| N214755-001 | 12109186 | 2037-07-21 | Drug product | 2024-10-15 | |
| N214755-001 | 12115142 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-001 | 12115143 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-001 | 12115144 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-001 | 12115145 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-001 | 12128021 | 2037-07-21 | U-4022 | 2024-11-12 | |
| N214755-001 | 12138239 | 2037-07-21 | Drug product | 2024-11-15 | |
| N214755-001 | 12144793 | 2037-07-21 | Drug product | 2024-11-22 | |
| N214755-001 | 12303478 | 2037-07-21 | U-4189 | 2025-06-02 | |
| N214755-001 | 11583510 | 2042-02-07 | U-3578 | 2023-05-23 | |
| N214755-001 | 11779557 | 2042-03-16 | U-3705 | 2023-10-24 | |
| N214755-002 | 10272062 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-002 | 10736866 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-002 | 10952986 | 2037-07-21 | U-3601 | 2023-05-23 | |
| N214755-002 | 10973795 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-002 | 11000498 | 2037-07-21 | U-3580 | Drug product | 2023-05-23 |
| N214755-002 | 11052061 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-002 | 11065224 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-002 | 11400065 | 2037-07-21 | U-3579 | 2023-05-23 | |
| N214755-002 | 11504347 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-002 | 11602512 | 2037-07-21 | U-3577 | 2023-05-23 | |
| N214755-002 | 11602513 | 2037-07-21 | U-3576 | 2023-05-23 | |
| N214755-002 | 11766418 | 2037-07-21 | Drug product | 2023-09-29 | |
| N214755-002 | 11826335 | 2037-07-21 | U-3751 | 2023-12-04 | |
| N214755-002 | 11839597 | 2037-07-21 | Drug product | 2024-01-04 | |
| N214755-002 | 11896572 | 2037-07-21 | Drug product | 2024-02-20 | |
| N214755-002 | 11986451 | 2037-07-21 | U-3934 | 2024-05-29 | |
| N214755-002 | 12097175 | 2037-07-21 | Drug product | 2024-10-15 | |
| N214755-002 | 12097176 | 2037-07-21 | U-4006 | 2024-10-15 | |
| N214755-002 | 12109186 | 2037-07-21 | Drug product | 2024-10-15 | |
| N214755-002 | 12115142 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-002 | 12115143 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-002 | 12115144 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-002 | 12115145 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-002 | 12128021 | 2037-07-21 | U-4022 | 2024-11-12 | |
| N214755-002 | 12138239 | 2037-07-21 | Drug product | 2024-11-15 | |
| N214755-002 | 12144793 | 2037-07-21 | Drug product | 2024-11-22 | |
| N214755-002 | 12303478 | 2037-07-21 | U-4189 | 2025-06-02 | |
| N214755-002 | 11583510 | 2042-02-07 | U-3578 | 2023-05-23 | |
| N214755-002 | 11779557 | 2042-03-16 | U-3705 | 2023-10-24 | |
| N214755-003 | 10272062 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-003 | 10736866 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-003 | 10952986 | 2037-07-21 | U-3601 | 2023-05-23 | |
| N214755-003 | 10973795 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-003 | 11000498 | 2037-07-21 | U-3580 | Drug product | 2023-05-23 |
| N214755-003 | 11052061 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-003 | 11065224 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-003 | 11400065 | 2037-07-21 | U-3579 | 2023-05-23 | |
| N214755-003 | 11504347 | 2037-07-21 | Drug product | 2023-05-23 | |
| N214755-003 | 11602512 | 2037-07-21 | U-3577 | 2023-05-23 | |
| N214755-003 | 11602513 | 2037-07-21 | U-3576 | 2023-05-23 | |
| N214755-003 | 11766418 | 2037-07-21 | Drug product | 2023-09-29 | |
| N214755-003 | 11839597 | 2037-07-21 | Drug product | 2024-01-04 | |
| N214755-003 | 11896572 | 2037-07-21 | Drug product | 2024-02-20 | |
| N214755-003 | 11986451 | 2037-07-21 | U-3934 | 2024-05-29 | |
| N214755-003 | 12097175 | 2037-07-21 | Drug product | 2024-10-15 | |
| N214755-003 | 12097176 | 2037-07-21 | U-4006 | 2024-10-15 | |
| N214755-003 | 12109186 | 2037-07-21 | Drug product | 2024-10-15 | |
| N214755-003 | 12115142 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-003 | 12115143 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-003 | 12115144 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-003 | 12115145 | 2037-07-21 | Drug product | 2024-10-22 | |
| N214755-003 | 12128021 | 2037-07-21 | U-4022 | 2024-11-12 |
Orange Book exclusivity#
| Application-product | Exclusivity code | Expiration |
|---|---|---|
| N214755-001 | NP | 2026-05-01 |
| N214755-001 | ODE-431 | 2030-05-01 |
| N214755-001 | ODE-494 | 2031-10-16 |
| N214755-002 | NP | 2026-05-01 |
| N214755-002 | ODE-431 | 2030-05-01 |
| N214755-002 | ODE-494 | 2031-10-16 |
| N214755-003 | NP | 2026-05-01 |
| N214755-003 | ODE-431 | 2030-05-01 |
| N214755-003 | ODE-494 | 2031-10-16 |
| N214755-004 | NP | 2026-05-01 |
| N214755-004 | ODE-431 | 2030-05-01 |
| N214755-004 | ODE-494 | 2031-10-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | LUMRYZ | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | LUMRYZ | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-003 | LUMRYZ | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-004 | LUMRYZ | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-001 | LUMRYZ | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-002 | LUMRYZ | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-003 | LUMRYZ | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-004 | LUMRYZ | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-001 | LUMRYZ | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-002 | LUMRYZ | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-003 | LUMRYZ | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-004 | LUMRYZ | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214755-001 | LUMRYZ | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214755-002 | LUMRYZ | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214755-003 | LUMRYZ | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214755-004 | LUMRYZ | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214755-001 | LUMRYZ | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214755-002 | LUMRYZ | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214755-003 | LUMRYZ | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N214755-004 | LUMRYZ | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214755-001 | LUMRYZ | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214755-002 | LUMRYZ | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214755-003 | LUMRYZ | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N214755-004 | LUMRYZ | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214755-001 | LUMRYZ | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214755-002 | LUMRYZ | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214755-003 | LUMRYZ | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N214755-004 | LUMRYZ | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214755-001 | LUMRYZ | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214755-002 | LUMRYZ | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214755-003 | LUMRYZ | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N214755-004 | LUMRYZ | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214755-001 | LUMRYZ | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214755-002 | LUMRYZ | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214755-003 | LUMRYZ | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N214755-004 | LUMRYZ | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214755-001 | LUMRYZ | 4.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD, RS | 2023-05-01 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214755-002 | LUMRYZ | 6GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214755-003 | LUMRYZ | 7.5GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N214755-004 | LUMRYZ | 9GM/PACKET | FOR SUSPENSION, EXTENDED RELEASE / ORAL | RLD | 2023-05-01 | d06236e962d9… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 10272062 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 10736866 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 10952986 | 2037-07-21 | U-3601 | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 10973795 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11000498 | 2037-07-21 | U-3580 | Drug product | 2023-05-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11052061 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11065224 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11400065 | 2037-07-21 | U-3579 | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11504347 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11602512 | 2037-07-21 | U-3577 | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11602513 | 2037-07-21 | U-3576 | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11766418 | 2037-07-21 | Drug product | 2023-09-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11839597 | 2037-07-21 | Drug product | 2024-01-04 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11896572 | 2037-07-21 | Drug product | 2024-02-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11986451 | 2037-07-21 | U-3934 | 2024-05-29 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12097175 | 2037-07-21 | Drug product | 2024-10-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12097176 | 2037-07-21 | U-4006 | 2024-10-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12109186 | 2037-07-21 | Drug product | 2024-10-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12115142 | 2037-07-21 | Drug product | 2024-10-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12115143 | 2037-07-21 | Drug product | 2024-10-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12115144 | 2037-07-21 | Drug product | 2024-10-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12115145 | 2037-07-21 | Drug product | 2024-10-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12128021 | 2037-07-21 | U-4022 | 2024-11-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12138239 | 2037-07-21 | Drug product | 2024-11-15 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12144793 | 2037-07-21 | Drug product | 2024-11-22 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12226377 | 2037-07-21 | Drug product | 2025-02-21 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 12303478 | 2037-07-21 | U-4189 | 2025-06-02 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 10925844 | 2040-02-28 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11583510 | 2042-02-07 | U-3578 | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | 11779557 | 2042-03-16 | U-3705 | 2023-10-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | 10272062 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | 10736866 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | 10952986 | 2037-07-21 | U-3601 | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | 10973795 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | 11000498 | 2037-07-21 | U-3580 | Drug product | 2023-05-23 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | 11052061 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | 11065224 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | 11400065 | 2037-07-21 | U-3579 | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | 11504347 | 2037-07-21 | Drug product | 2023-05-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | 11602512 | 2037-07-21 | U-3577 | 2023-05-23 | 011fe1cb6892… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | NP | 2026-05-01 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | ODE-431 | 2030-05-01 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-001 | ODE-494 | 2031-10-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | NP | 2026-05-01 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | ODE-431 | 2030-05-01 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-002 | ODE-494 | 2031-10-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-003 | NP | 2026-05-01 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-003 | ODE-431 | 2030-05-01 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-003 | ODE-494 | 2031-10-16 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-004 | NP | 2026-05-01 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-004 | ODE-431 | 2030-05-01 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N214755-004 | ODE-494 | 2031-10-16 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-001 | NP | 2026-05-01 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-001 | ODE-431 | 2030-05-01 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-001 | ODE-494 | 2031-10-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-002 | NP | 2026-05-01 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-002 | ODE-431 | 2030-05-01 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-002 | ODE-494 | 2031-10-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-003 | NP | 2026-05-01 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-003 | ODE-431 | 2030-05-01 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-003 | ODE-494 | 2031-10-16 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-004 | NP | 2026-05-01 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-004 | ODE-431 | 2030-05-01 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N214755-004 | ODE-494 | 2031-10-16 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-001 | NP | 2026-05-01 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-001 | ODE-431 | 2030-05-01 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-001 | ODE-494 | 2031-10-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-002 | NP | 2026-05-01 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-002 | ODE-431 | 2030-05-01 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-002 | ODE-494 | 2031-10-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-003 | NP | 2026-05-01 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-003 | ODE-431 | 2030-05-01 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-003 | ODE-494 | 2031-10-16 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-004 | NP | 2026-05-01 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-004 | ODE-431 | 2030-05-01 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N214755-004 | ODE-494 | 2031-10-16 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214755-001 | NP | 2026-05-01 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214755-001 | ODE-431 | 2030-05-01 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214755-001 | ODE-494 | 2031-10-16 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N214755-002 | NP | 2026-05-01 | fd3edfee7708… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lumryz
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| SODIUM OXYBATE | 7.5 g/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 7G33012534 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2636822 | Internal RxNorm lookup |
| 2636828 | Internal RxNorm lookup |
| 2636830 | Internal RxNorm lookup |
| 2636832 | Internal RxNorm lookup |
| 2636834 | Internal RxNorm lookup |
| 2636836 | Internal RxNorm lookup |
| 2636838 | Internal RxNorm lookup |
| 2636840 | Internal RxNorm lookup |
| 2698135 | Internal RxNorm lookup |
| 2698136 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 10e5e40c-52f3-4c73-8a34-2c29c690a934 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 2e88548e-cd6c-4b2e-a954-1bb23670f612 | Product name | 1 | 20231010 |
| b3e31acf-ce79-4bd9-845e-03c8d973021a | Product name | 1 | 20210203 |
| a3ec038e-96ea-8cce-3e80-6c56853019f6 | Product name | 2 | 20170424 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13551-003-07 | Lumryz | 1 in 1 PACKET | FOR SUSPENSION, EXTENDED RELEASE | 1 | 10 | |
| 13551-003-07 | Lumryz | 7 in 1 CARTON | FOR SUSPENSION, EXTENDED RELEASE | 7 | 10 | |
| 13551-003-30 | Lumryz | 30 in 1 CARTON | FOR SUSPENSION, EXTENDED RELEASE | 30 | 10 | |
| 13551-003-30 | Lumryz | 1 in 1 PACKET | FOR SUSPENSION, EXTENDED RELEASE | 1 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13551-003-07 | EA - Each | 13551-003 | 3ed520ff-ae1e-47fc-8f3a-c5bf4d3a74ef | 1 | 2023-06-06 |
| 13551-003-30 | EA - Each | 13551-003 | b9946d84-0eab-4677-8d23-6f0e34d9f44c | 1 | 2023-06-06 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lumryz | SODIUM OXYBATE | Avadel CNS Pharmaceuticals, LLC | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 214755 NDA214755 13551-003 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2698136 | {7 (sodium oxybate 4500 MG Granules for Oral Suspension [Lumryz]) / 14 (sodium oxybate 6000 MG Granules for Oral Suspension [Lumryz]) / 7 (sodium oxybate 7500 MG Granules for Oral Suspension [Lumryz]) } Pack [Lumryz 28-Day Starter Pack] | BPCK | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2698135 | {7 (sodium oxybate 4500 MG Granules for Oral Suspension) / 14 (sodium oxybate 6000 MG Granules for Oral Suspension) / 7 (sodium oxybate 7500 MG Granules for Oral Suspension) } Pack | GPCK | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2698136 | Lumryz 28-Day Starter Pack | PSN | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636828 | Lumryz 4.5 GM Granules for extended release Oral Suspension | PSN | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636832 | Lumryz 6 GM Granules for extended release Oral Suspension | PSN | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636836 | Lumryz 7.5 GM Granules for extended release Oral Suspension | PSN | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636840 | Lumryz 9 GM Granules for extended release Oral Suspension | PSN | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2698135 | sodium oxybate 28-Day Starter Pack | PSN | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636822 | sodium oxybate 4.5 GM Granules for extended release Oral Suspension | PSN | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636830 | sodium oxybate 6 GM Granules for extended release Oral Suspension | PSN | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636834 | sodium oxybate 7.5 GM Granules for extended release Oral Suspension | PSN | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636838 | sodium oxybate 9 GM Granules for extended release Oral Suspension | PSN | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636828 | sodium oxybate 4500 MG Granules for Oral Suspension [Lumryz] | SBD | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636832 | sodium oxybate 6000 MG Granules for Oral Suspension [Lumryz] | SBD | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636836 | sodium oxybate 7500 MG Granules for Oral Suspension [Lumryz] | SBD | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636840 | sodium oxybate 9000 MG Granules for Oral Suspension [Lumryz] | SBD | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636822 | sodium oxybate 4500 MG Granules for Oral Suspension | SCD | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636830 | sodium oxybate 6000 MG Granules for Oral Suspension | SCD | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636834 | sodium oxybate 7500 MG Granules for Oral Suspension | SCD | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636838 | sodium oxybate 9000 MG Granules for Oral Suspension | SCD | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2698136 | Lumryz 28-Day Starter Pack | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636828 | Lumryz 4.5 GM (equivalent to 3.7 GM oxybate) Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636828 | Lumryz 4500 MG Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636832 | Lumryz 6 GM (equivalent to 5 GM oxybate) Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636832 | Lumryz 6000 MG Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636836 | Lumryz 7.5 GM (equivalent to 6.2 GM oxybate) Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636836 | Lumryz 7500 MG Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636840 | Lumryz 9 GM (equivalent to 7.4 GM oxybate) Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636840 | Lumryz 9000 MG Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2698135 | sodium oxybate 28-Day Starter Pack | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636822 | sodium oxybate 4.5 GM (equivalent to 3.7 GM oxybate) Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636830 | sodium oxybate 6 GM (equivalent to 5 GM oxybate) Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636834 | sodium oxybate 7.5 GM (equivalent to 6.2 GM oxybate) Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
| 2636838 | sodium oxybate 9 GM (equivalent to 7.4 GM oxybate) Granules for Oral Suspension | SY | 10e5e40c-52f3-4c73-8a34-2c29c690a934 | 10 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 13551-003-07 | 13551000307 | 7 PACKET in 1 CARTON (13551-003-07) / 1 FOR SUSPENSION, EXTENDED RELEASE in 1 PACKET | 7 packet | 2023-05-01 | No | No | Current |
| 13551-003-30 | 13551000330 | 30 PACKET in 1 CARTON (13551-003-30) / 1 FOR SUSPENSION, EXTENDED RELEASE in 1 PACKET | 30 packet | 2023-05-01 | No | No | Current |